Michael Landine
Corporate Officer/Principal at ALKERMES PLC
Net worth: 8 M $ as of 31/03/2024
Profile
Michael J.
Landine's current job is as the SVP-Corporate Development at Alkermes Plc.
Formerly, he worked as an Independent Director at Kopin Corp.
from 2003 to 2019.
He also served as a Director at Expressive Constructs, Inc. and rEVO Biologics, Inc. from 2004 to 2012.
Additionally, he held the position of CFO, Treasurer & Senior VP-Corporate Development at Alkermes, Inc. from 1988 to 2012.
He was also the Chief Financial Officer at Walker Magnetics Group, Inc.Mr. Landine obtained his undergraduate degree from Bentley University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 23/02/2024 | 281,730 ( 0.17% ) | 8 M $ | 31/03/2024 |
Michael Landine active positions
| Companies | Position | Start |
|---|---|---|
| ALKERMES PLC | Corporate Officer/Principal | 01/09/2011 |
Former positions of Michael Landine
| Companies | Position | End |
|---|---|---|
| KOPIN CORPORATION | Director/Board Member | 01/01/2019 |
Expressive Constructs, Inc.
 Expressive Constructs, Inc. Pharmaceuticals: OtherHealth Technology Expressive Constructs, Inc. researches and develops antibody detection technologies. The company's products include diagnostic sensor for urinary tract infections and wound care systems that provide warning of emergent infections and promote healing. It was founded by Mitch Sanders in 1998 and is headquartered in Worcester, MA. | Director/Board Member | 01/02/2013 |
| REVO BIOLOGICS INC | Director/Board Member | 06/12/2010 |
Walker Magnetics Group, Inc.
 Walker Magnetics Group, Inc. Tools & HardwareConsumer Durables Walker Magnetics Group, Inc. design and manufactures magnetic products for workholding, lifting, material handling, scrap magnets, and separation applications. The company was founded by Oakley S. Walker in 1896 and is headquartered in Worcester, MA. | Director of Finance/CFO | - |
Alkermes, Inc.
 Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Director of Finance/CFO | 30/05/2012 |
Training of Michael Landine
| Bentley University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| KOPIN CORPORATION | Electronic Technology |
| ALKERMES PLC | Health Technology |
| Private companies | 4 |
|---|---|
Alkermes, Inc.
Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Health Technology |
Expressive Constructs, Inc.
Expressive Constructs, Inc. Pharmaceuticals: OtherHealth Technology Expressive Constructs, Inc. researches and develops antibody detection technologies. The company's products include diagnostic sensor for urinary tract infections and wound care systems that provide warning of emergent infections and promote healing. It was founded by Mitch Sanders in 1998 and is headquartered in Worcester, MA. | Health Technology |
Walker Magnetics Group, Inc.
Walker Magnetics Group, Inc. Tools & HardwareConsumer Durables Walker Magnetics Group, Inc. design and manufactures magnetic products for workholding, lifting, material handling, scrap magnets, and separation applications. The company was founded by Oakley S. Walker in 1896 and is headquartered in Worcester, MA. | Consumer Durables |
rEVO Biologics, Inc.
 rEVO Biologics, Inc. BiotechnologyHealth Technology rEVO Biologics, Inc. engages in the development and commercialization of specialty therapeutics to address unmet medical needs in patients with rare, life-threatening conditions. Its products include ATryn, which prevents blood clots during and after surgery and childbirth for patients with hereditary antithrombin deficiency. The company was founded in February 1993 and is headquartered in Framingham, MA. | Health Technology |
- Stock Market
- Insiders
- Michael Landine
